| HealthPartners | Medical injectable medication quantity and frequency | 2026-01-01 |
| HealthPartners | Nusinersen (Spinraza®) | 2026-01-01 |
| HealthPartners | Nusinersen (Spinraza®) – Minnesota Health Care | 2026-01-01 |
| HealthPartners | Ocular anti-VEGF medications | 2026-01-01 |
| HealthPartners | Olipudase alfa-rpcp (Xenpozyme™) | 2026-01-01 |
| HealthPartners | Oncology - asparaginase erwinia chryanthemi | 2026-01-01 |
| HealthPartners | Oncology - belantamab (Blenrep®) – Minnesota Health | 2026-01-01 |
| HealthPartners | Oncology - bevacizumab (Avastin®, Mvasi™, Zirabev® | 2026-01-01 |
| HealthPartners | Oncology - bevacizumab (Avastin®, Mvasi™, | 2026-01-01 |
| HealthPartners | Oncology - blinatumomab (Blincyto™) | 2026-01-01 |